VIENVA Trademark

Trademark Overview

On Tuesday, May 26, 2015, a trademark application was filed for VIENVA with the United States Patent and Trademark Office. The USPTO has given the VIENVA trademark a serial number of 86640742. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Tuesday, March 26, 2024. This trademark is owned by Novartis AG. The VIENVA trademark is filed in the Pharmaceutical Products category with the following description:

Oral contraceptives
vienva

General Information

Serial Number86640742
Word MarkVIENVA
Filing DateTuesday, May 26, 2015
Status701 - SECTION 8 - ACCEPTED
Status DateTuesday, March 26, 2024
Registration Number5396790
Registration DateTuesday, February 6, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 1, 2016

Trademark Statements

Amendment to a Registration/Renewal CertificateIssue New Certificate to: XIROMED PHARMA ESPAÑA S.L. (Spain Limited Liability Company) 3a y 4a planta Calle Manuel Pombo Angulo 28 Madrid Spain 28050
Certificate of Correction for RegistrationIn the statement, lines 1 thru 3, "NOVARTIS AG (SWITZERLAND CORPORATION), CH-4002, BASEL, SWITZERLAND" should be deleted, and LABORATORIOS LEÓN FARMA, S.A. (SPAIN COMPANY), CALLE LA VALLINA S/N P.I. NAVATEJERA LEÓN SPAIN 24008 should be inserted.
Goods and ServicesOral contraceptives
Translation of Words in MarkThe word(s) "VIENVA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 1, 2015
Primary Code005
First Use Anywhere DateMonday, January 4, 2016
First Use In Commerce DateMonday, January 4, 2016

Trademark Owner History

Party NameXIROMED PHARMA ESPAÑA S.L.
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressMadrid 28050
ES
Party NameLaboratorios León Farma, S.A.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressP.I. Navatejera, León 24008
ES
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Friday, July 10, 2015NON-FINAL ACTION WRITTEN
Friday, May 29, 2015NEW APPLICATION ENTERED
Monday, June 1, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 8, 2015ASSIGNED TO EXAMINER
Friday, July 10, 2015NON-FINAL ACTION E-MAILED
Friday, July 10, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 4, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 19, 2016ASSIGNED TO LIE
Thursday, January 21, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 21, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 22, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 28, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 10, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 1, 2016PUBLISHED FOR OPPOSITION
Tuesday, March 1, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 26, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, October 23, 2016SOU TEAS EXTENSION RECEIVED
Sunday, October 23, 2016SOU EXTENSION 1 FILED
Sunday, October 23, 2016SOU EXTENSION 1 GRANTED
Tuesday, October 25, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 14, 2017SOU TEAS EXTENSION RECEIVED
Friday, April 14, 2017SOU EXTENSION 2 FILED
Friday, April 14, 2017SOU EXTENSION 2 GRANTED
Tuesday, April 18, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 21, 2017TEAS STATEMENT OF USE RECEIVED
Thursday, September 21, 2017USE AMENDMENT FILED
Saturday, September 30, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, September 30, 2017STATEMENT OF USE PROCESSING COMPLETE
Friday, October 20, 2017ASSIGNED TO EXAMINER
Sunday, November 5, 2017SU - NON-FINAL ACTION - WRITTEN
Sunday, November 5, 2017NON-FINAL ACTION E-MAILED
Sunday, November 5, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 11, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 14, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 14, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 14, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 14, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 3, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, January 4, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, January 17, 2018ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, February 6, 2018REGISTERED-PRINCIPAL REGISTER
Thursday, May 3, 2018TEAS SECTION 7 REQUEST RECEIVED
Friday, June 1, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, June 5, 2018POST REGISTRATION ACTION MAILED - SEC. 7
Tuesday, December 4, 2018TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Wednesday, January 29, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, February 24, 2020CORRECTION UNDER SECTION 7 - PROCESSED
Friday, May 14, 2021TEAS SECTION 7 REQUEST RECEIVED
Tuesday, October 12, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, October 12, 2021NEW CERTIFICATE UNDER SECTION 7 - PROCESSED
Monday, February 6, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, January 9, 2024TEAS SECTION 8 RECEIVED
Monday, March 25, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, March 26, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED
Monday, July 21, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 21, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 21, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 26, 2024NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

Related Keywords

vienva contraceptives oral